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To report 6 new patients with cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
(CEDNIK) syndrome.
Methods
Clinical exome or targeted sequencing were performed to elucidate the molecular genetic cause
in patients with neurocognitive abnormalities and brain imaging findings.
Results
CEDNIK syndrome is a rare genetic condition caused by biallelic pathogenic loss-of-function
variants in synaptosomal-associated protein 29 (SNAP29), which encodes a vesicular mem-
brane fusion protein. Clinical manifestations include significant developmental delay/
intellectual disability (DD/ID), brain abnormalities, failure to thrive, and skin abnormalities.
To date, 19 patients from 10 unrelated families with CEDNIK syndrome have been reported.
We report 5 additional patients with homozygous predicted loss-of-function variants in
SNAP29 and one with compound heterozygous variants: a frameshift SNAP29 variant and a
370 kb deletion on 22q11.2. All patients exhibit DD/ID, ichthyosis and/or palmoplantar
keratoderma, and hypotonia. Four of 6 subjects had hypomyelinated white matter onMRI, 2 of
6 had early puberty, and 4 of 6 had strabismus, which were previously rarely reported. Other
phenotypes were variably present, including dysmorphic features, feeding difficulties, and re-
current respiratory infections. The cohort includes 2 siblings with a c.2T>C variant who have a
relatively milder phenotype, a patient with the most C-terminal variant yet described
(c.622G>T), and 3 patients with previously described variants (c.354dupG, c.487dupA).
Conclusions
This cohort of 6 additional patients expands the genotypic and phenotypic spectrum of
CEDNIK syndrome, highlighting previously under-recognized features such as hypomyelina-
tion, seizures, and early puberty. Owing to reduced penetrance of the skin phenotype, cerebral
dysgenesis, and neuropathy, we propose renaming this syndrome SNAP29-related disorder.
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Cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
(CEDNIK) syndrome (MIM# 609528) was first described by
Sprecher et al.1 in 2005, and to date, 19 individuals from 10
unrelated families have been described.2–9 This is a rare au-
tosomal recessive disease caused by loss-of-function variants
in synaptosomal-associated protein 29 (SNAP29). SNAP29 is
involved in membrane fusion processes including exocytosis,
endocytosis, autophagy, and ciliogenesis. In human skin and
animal models, loss of SNAP29 leads to abnormal maturation,
spatial organization, and differentiation of epidermal layers,
neurons, and muscle fibers.1,10–13
CEDNIK syndrome is characterized by severe neurologic ab-
normalities leading to global developmental delay, hypotonia, and
neuropathy as well as dermatologic abnormalities (ichthyosis and
keratoderma). Typical MRI findings are hypoplasia/dysplasia of
the corpus callosum and polymicrogyria (PMG). Congenital
hypotonia leads to feeding difficulties, failure to thrive, and de-
velopment of limb spasticity. Individuals with CEDNIK syn-
dromemeet few developmental milestones and often have vision
or hearing loss. Most patients have dysmorphic facial features
without a recognizable gestalt. Prognosis is poor; the eldest pa-
tient was 13 year old at publication, and 4 patients died of
pneumonia between ages 5 and 12.1,8
Here, we describe 6 additional patients with CEDNIK syn-
drome from 5 unrelated families, one of whom is older than
any previous patient described. Their genotypes include a
novel C-terminal predicted pathogenic variant in SNAP29 and
a variant previously associated with Pelizaeus-Merzbacher-like
disorder (PMLD).7
Methods
Standard Protocol Approvals, Registrations,
and Patient Consents
Written informed consent and authorization for publication
was received from patients’ guardians. The Washington
University in St. Louis Media Authorization for the Use and
Disclosure of Protected Health Information formwas used for
all patients except patient 4, who used the Kingston General
Hospital Consent for Photography form.
Genetic Testing
Next-generation sequencing was performed at each in-
stitution on a clinical basis for evaluation of specific findings
(see also Supplementary Material-B). For patients 1 and 4,
trio exome sequencing was performed through GeneDx
(Gaithersburg, MD). Patient 2 had targeted testing (GeneDx)
for the familial pathogenic variant previously found in his
sister. For patient 3, a chromosomal microarray analysis
(CMA) was performed at Children’s Hospital Los Angeles.
An XomeDxSlice (GeneDx) was performed to sequence
candidate genes SNAP29 and PEX7. Patient 5 had a CMA,
followed by exome sequencing by Genome Diagnostics
(Nijmegen, The Netherlands). Patient 6 had exome se-
quencing by Mendelics (Sao Paolo, Brazil).
Clinical History
Clinical history was obtained from chart review and/or dis-
cussion with the patient’s parents. Growth and occipitofrontal
circumference (OFC) percentiles refer to World Health Or-
ganization charts for ≤2 years of age and Centers for Disease
Control Prevention charts for >2 years.
Statistics
“N-1” χ2 test with 2-tailed p value (medcalc.org) was used to
compare proportions between groups.
Data Availability




Table 1 and figure 1A diagram shows the SNAP29 variants in
the 6 patients in this cohort compared with previously
reported cases.
Patients 1 and 2 are homozygous for a c.2T>C variant in
SNAP29. This is predicted to alter the initiation codon with
uncertain protein product (p.Met1?) and was previously
reported as a compound heterozygous variant in a patient
with PMLD.7
Patient 3 has a region of homozygosity detected by CMA at
chromosome 22q11.2 encompassing 32 OMIM genes. Tar-
geted testing revealed a homozygous frameshift pathogenic
variant (c.354dupG; p.Leu119Alafs*15) in SNAP29, which
was previously associated with CEDNIK syndrome.6
Patient 4 has a homozygous c.622G>T; p.Glu208* nonsense
variant in the last exon of SNAP29. This variant is the most
C-terminal yet described. In addition, CMA showed a 1.22
Mb duplication of unclear clinical significance at 8p23.2
containing CSMD1, deletions of which have been associated
with head and neck cancers.14
Glossary
CMA = chromosomal microarray analysis;DD = developmental delay; ID = intellectual disability;NMD = nonsense-mediated
mRNA decay; OFC = occipitofrontal circumference; PMG = polymicrogyria; PMLD = Pelizaeus-Merzbacher-like disorder;
SNAP29 = synaptosomal-associated protein 29.
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Patient 5 has a homozygous, previously described pathogenic
frameshift variant in SNAP29 designated c.487dupA;
p.Ser163Lysfs*6. Cell culture experiments suggest that the
mutated protein is produced at normal levels with abnormal
localization.2
Patient 6’s exome sequencing revealed a heterozygous
c.354dupG; pLeu119Alafs*15 mutation in SNAP29 and an
approximately 370 kb deletion in 22q11.2 encompassing 4
OMIM genes (SNAP29, PI4KA, SERPIND1, and LZTR1).
Biallelic PI4KA variants in 3 unborn fetuses were associated
with PMG, cerebellar hypoplasia, and arthrogryposis (MIM




Patient 1 is a 19-year-old woman of mixed Amish and Men-
nonite heritage whose parents estimate they are fifth cousins
(figure 1B). Pregnancy was complicated by maternal malarial
infection, but she was born at full-term without significant
complications.
Patient 1 had no significant health problems in her first year of
life. She was late to walk (24 months) and talk (2–3 years).
She developed seizures at the age of 4; EEG showed multi-
focal epileptiform discharges. Repeat EEG at the age of 8
showed discharges in the left occipital and bilateral temporal
regions. Seizures stopped on antiepileptic medication by the
age of 10. She had premature thelarche with breast de-
velopment at the age of 7, but menstruation began at the age
of 9. She lost motor and speech milestones at the age of
12–13. She uses a wheelchair but walks with assistance. She
knows few words, and her speech is dysarthric. She is hy-
peropic and required 3 corrective surgeries for strabismus. She
exhibits constipation.
On physical examination at the age of 18, her height, weight,
and OFC were <1st, 22nd, and 40th percentile, respectively.
She has mild hypotelorism, a round face, and slightly deep-
set eyes (figure 2A). Dermatologic findings include mild
Table 1 SNAP29 Mutations Described to Date
Ref. N Ethnicity SNAP29 variant Predicted protein change
1 6 sibs Arab c.223delG p.Val75Serfs*28
1 Arab c.223delG p.Val75Serfs*28
2 2 sibs Kashmiri Pakistani c.487dupA p.Ser163Lysfs*6
3 2 sibs Jordanian c.223delG p.Val75Serfs*28
4 1 Jordanian c.85C>T p.Arg29*
5 1 Indian c.253C>T p.Arg85*
6 1 N/A c.354dupG p.Leu119Alafs*15
7 1 Caucasian, Hispanic c.2T>C, c.354dupG p.Met1?; p.Leu119Alafs*15
8, 9 3 sibs Pakistani c.487dupA p.Ser163Lysfs*6
1 Pakistani c.487dupA p.Ser163Lysfs*6
16 1 N/A c.388insGA, D22q11.2 p.Thr130Argfs*17
1 N/A c.28delCCGTT, D22q11.2 p.Pro10Argfs*42
1 N/A c.265G>A, D22q11.2 p.Glu89Lys
1 N/A c.268C>T, D22q11.2 p.Arg90Cys
This paper 2 sibs (Pts 1, 2) Amish, Mennonite c.2T>C p.Met1?
1 (Pt 3) Hispanic Mexican c.354dupG p.Leu119Alafs*15
1 (Pt 4) Tibetan, Indian c.622G>T p.Glu208*
1 (Pt 5) Arab c.487dupA p.Ser163Lysfs*6
1 (Pt 6) Brazilian c.354dupG, 370kb deletion p.Leu119Alafs*15
Notation per Human Genome Structural Variation Consortium 2016 guidelines.
* Indicates stop codon, fs*# indicates frame shift producing # mutated amino acids (including the stop codon), ? indicates unknown product, Δ indicates
microdeletion leading to 22q11.2 deletion syndrome. Patients are homozygous for variant listed unless 2 variants listed. Please note that Sprecher et al.1 refer
to c.223delG in their publication as c.220delG as they started numbering after the initiation codon.
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ichthyosis on her limbs and palmoplantar keratoderma
(figure 2B). Examination revealed truncal hypotonia, lower
extremity hypertonia/clonus with hamstring tightness, and
scoliosis.
Patient 2
Patient 2 is a 13-year-old boy and the youngest sibling of
patient 1 (figure 1B). He was delivered at term after an un-
complicated pregnancy and required oxygen supplementation
for 2 hours for respiratory distress.
Patient 2 had no significant health problems as an infant. He
had a seizure at the age of 3 but did not require antiepileptics
and had a normal EEG. His DD is less severe than patient 1’s;
he sat without support and crawled at 7 mo, walked at 18 mo,
and can run, jump, and ride a bike with training wheels. He
can trace words, count to 13, and speaks in short sentences
with some dysarthria and a significant stutter. He had one
surgery for strabismus and wears glasses for hyperopia. His
pubertal development has been normal.
On physical examination at the age of 12, patient 2’s height,
weight, and OFC were normal. His facial features are similar
to his sister’s, with more severe dermatological involvement
including wide-spread ichthyosis and keratoderma of his soles
(figure e-1, links.lww.com/NXG/A366). Examination
showed truncal hypotonia, lower extremity hypertonia with
tight hamstrings, hyperreflexia, and a dragging wide-based
gait.
Patient 3
Patient 3 is a 9-year-old girl of Hispanic Mexican descent
whose parents estimate they are second cousins. The proband
was the mother’s fifth pregnancy; her 4 older brothers are
healthy, although one has ADHD (figure 1B).
At birth, patient 3 had difficulty feeding and received a G-tube
at the age of 2 for failure to thrive. She was diagnosed with
cerebral palsy with spastic diplegia. Breast development
started at the age of 8 (early normal). She has global DD; at 9
years, she can sit, crawl, walk for 1 minute with assistance, and
speaks one 2-word phrase. She has been hospitalized for re-
current pneumonia and bronchiolitis. She received corrective
surgery for strabismus. She takes levothyroxine for hypothy-
roidism, gabapentin for spasticity, and laxatives for
constipation.
Figure 1 Mutation Map of SNAP29 Variants and CEDNIK Case Report Pedigrees
(A) SNAP29 variants shown by cDNA position and
nucleotide change with notations per Human
Genome Structural Variation Consortium 2016
guidelines. Listed next to each variant are asso-
ciated cases, noted as labelled gray circles. Labels
#1–6 (light gray) indicate patients reported in this
manuscript. Lettered labels indicate cases
reported by previous reports (dark gray), noted
by the first author’s last initial. Please note, all
patients carry homozygous variants except L1
(compound heterozygous),7 M1-4 (hemizygous,
gray arrows),16 and patient 6 (hemizygous). (B)
Patient pedigrees. Symbol key: =consanguineous
marriage, circle: female, square: male, triangle:
miscarriage, filled: affected (numbers refer to
subjects in this cohort), half-filled: known
asymptomatic carrier. Note both miscarriages
were first trimester and did not undergo genetic
testing. cDNA = complementary DNA; CEDNIK =
cerebral dysgenesis, neuropathy, ichthyosis, and
keratoderma; SNAP29 = synaptosomal-associ-
ated protein 29.
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On physical examination at the age of 7, her height and weight
were <1st and 11th percentile, respectively. She is microcephalic
with bitemporal narrowing and has thick eyebrows, epicanthal
folds, and flaring nares with a bulbous nasal tip. Her skin exam-
ination showed diffuse ichthyosis that peels extensively every few
days and palmoplantar keratoderma (figure e-1, links.lww.com/
NXG/A366). She is nonverbal and exhibits repetitive behaviors,
purposeless movements, and roving eye movements. Ophthal-
mologic examination showed nystagmus and foveal hypoplasia.
Neurologic examination showed increased muscle tone in the
lower extremities and bilateral sensorineural deafness.
Patient 4
Patient 4 is a 4-year-old girl of Tibetan & Indian descent. Her
parents have no known consanguinity. She was the second of
3 pregnancies and delivered at full term; her siblings are
healthy (figure 1B).
At 18 months, patient 4 required a G-tube for feeding diffi-
culties and poor weight gain. She has global DD complicated
by cortical visual impairment and profound sensorineural
deafness. At the age of 4, she can form a pincer grasp but is
unable to walk because of profound hypotonia. She does not
speak. She had multiple admissions for aspiration pneumonia.
She takes omeprazole for gastroesophageal reflux, domper-
idone for gastrointestinal dysmotility, and salbutamol and
fluticasone propionate for asthma.
On physical examination at the age of 3, height, weight, and
OFC were 3–10th, 10th, and 50th percentile, respectively.
Dysmorphic features include plagiocephaly, right-hand single
palmar crease, and thinning hair at the temporal regions. Skin
examination showed ichthyosis without keratoderma (figure
e-1, links.lww.com/NXG/A366). Ophthalmologic examina-
tion showed hyperopia, nystagmus, and strabismus.
Patient 5
Patient 5 is a 7-year-old boy of Arabian descent whose parents
are third cousins (figure 1B). He was born at term after an
uncomplicated pregnancy and noted to have craniofacial
dysmorphism, hypotonia, and nystagmus at birth.
During infancy, patient 5 had feeding difficulties, gastro-
esophageal reflux, failure to thrive, and recurrent respiratory
tract infections leading to multiple hospitalizations. He also
had a 1 mm patent foramen ovale that resolved. He developed
seizures at 4 months with multifocal epileptiform discharges
on EEG, for which he took phenobarbitone until seizures
resolved at the age of 2. At 2.5 years old, he was <2nd per-
centile for OFC and weight (from 12th and 34th at birth). He
sat with support at the age of 3 and stood with support at the
age of 3.5, but at the age of 7, he no longer stands in-
dependently. He holds a spoon but cannot feed himself. His
first word was at 2.5 years old, and his vocabulary is restricted
to 2 words.
On physical examination at the age of 6.5, height, weight,
and OFC were <2nd, 5th, and 2nd percentile, respectively.
Patient 5 has microcephaly with a short forehead and
bitemporal narrowing, low-set ears, microphthalmia, epi-
canthal folds, anteverted nares, a short philtrum with
bowed upper lip, micrognathia, and a high-arched palate
(figure 2C). Examination also showed hypotonia, scolio-
sis, and generalized ichthyosis without palmoplantar ker-
atoderma (figure 2D). Ophthalmologic examination
showed horizontal nystagmus, convergent strabismus, and
myopia.
Patient 6
Patient 6 is a 2-year-old Brazilian boy whose parents are second
cousins (figure 1B). He was born at term after an uncomplicated
Figure 2 Representative Facial Features and Skin Findings in Patients With CEDNIK
There was no recognizable gestalt of features among the patients described in this study. Patient 1 (age 18) displays (A) mild hypotelorism and (B)
keratoderma of the soles of the feet. Patient 5 (age 6) displays (C) short forehead with bitemporal narrowing, low-set ears, microphthalmia, high-arched
palate. Epicanthal folds, strabismus, anteverted nares, a short philtrum with bowed upper lip, micrognathia, a high-arched palate, and (D) generalized
ichthyosis, here shown on the back. CEDNIK = cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma.
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pregnancy and was noted to have shortened Achilles tendons. He
required a 1-month NICU stay for fever, hypoglycemia, and
thrombophilia, possibly related to SERPIND1/heparin cofactor II
deficiency (see Molecular Results).16
He eats well but has difficulty gaining weight. He has global
DD; at the age of 2, he sits with support but cannot walk and
babbles without producing words. He has significant hearing
loss and right optic nerve hypoplasia. He takes laxatives for
constipation and melatonin for difficulty sleeping.
At the age of 2, height, weight, and OFC were <2nd, 10th, and
;70th percentile, respectively. He has mildly dysmorphic
features with synophrys, bushy eyebrows, epicanthal folds,
and a broad, depressed nasal bridge. Skin findings include
ichthyosis and plantar keratoderma (figure e-1, links.lww.
com/NXG/A366). He has truncal hypotonia, poor limb
movement, and tight Achilles tendons.
Radiologic Findings
Typical radiographic findings of CEDNIK syndrome are dys-
genesis of the corpus callosum and PMG. Corpus callosum
dysgenesis was seen in the brain MRIs of all patients except
patient 3 (figures 3, e-3, e-4, e-5, links.lww.com/NXG/A366).
Patient 3’sMRIwas read as bilateral PMG, stable from18months
to 8 years of age (data not shown), and patient 4 has possible
PMG at the Sylvian fissures (figure e-4); patient 5’s MRIs at 4
days and 10months of age were initially reported as lissencephaly
with PMG and mild cerebellar hypoplasia, although this finding
was not clear on reread at another institution (figure 4).However,
imaging of patients 1, 2, and 6 did not show evidence of PMG.
The most striking and under-recognized finding in this cohort
of patients was white matter T1 hypointensity/T2 hyper-
intensity consistent with decreased sphingolipid in the myelin
sheath, characteristic of white matter disease. Patient 1 had
serial MRIs showing fairly normal supratentorial white matter
at 14 months of age but a striking lack of supratentorial myelin
signal by age 12 years (figure 3, e-2, links.lww.com/NXG/
A366). MR spectroscopy showed increased choline relative to
n-acetylaspartate, consistent with metabolic breakdown of the
myelin sheath.17 MRIs from patient 2 (age 3, figure e-3),
patient 4 (age 2, figure e-4), and patient 6 (7 months, data not
shown) also suggest decreased supratentorial myelin content.
Although less severe, patient 5 had subtle hypomyelination in
the occipital region at 10 months (figure 4). Loss of white
matter, especially in the occipital areas, may have led to en-
largement of the occipital horns of the lateral ventricles in
patients 2 (figure e-3), 5 (figure e-5), and 6 (data not shown).
We also describe several structural abnormalities that were
not previously associated with CEDNIK syndrome. Four
patients had an abnormal craniocervical junction with nar-
rowing of the foramen magnum, represented by imaging from
patient 1 showing platybasia with kinking of the medulla
oblongata (figure 3), but also present in patients 2, 4, and 5.
Representative imaging from patient 5 (figure 4) shows ab-
normalities in the Sylvian fissure that were also present in
patients 2 and 4, and T2 hyperintensity of the globus pallidi
shared with patient 4. T2 hyperintensity of the basal ganglia is
often linked to hypoxic, toxic, and/or metabolic insult, but its
underlying cause in CEDNIK syndrome is unclear.
Figure 3 Brain MRI of Patient 1 Shows Corpus Callosum
Dysgenesis and Loss of Supratentorial Myelin
(A) T1-weighted MRI showing normal myelination at 14 months but loss of
normal T1 hyperintense white matter signal at 12 years consistent with
severe hypomyelination (yellow arrows). (B) T1-weighted MRI showing
dysgenesis of the corpus callosumwith a deficient splenium. Although there
is normalmyelin in the genu of the corpus callosum at 14months, it is lost at
12 years (orange arrows). In addition, there is platybasia with resultant
kinking of the medulla oblongata. (C) Single voxel proton MR spectroscopy
with TE 144 ms at 12 years of age. Top row: T1W, T2 FLAIR, and T2W images
show abnormal white matter. Bottom row: spectrum shows elevated cho-
line relative to n-acetylaspartate (NAA) in the right frontal lobe whitematter,
consistent with the loss of sphingolipid in the myelin and suggestive of
myelin breakdown. A normal spectrum should show reversed levels of NAA
and choline.17.
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Discussion
We describe 6 additional patients with CEDNIK syndrome
and review previously reported phenotypes and genotypes.
To date, 10 distinct variants in SNAP29 are associated with
disease in humans (table 1, figure 1A), including 4 hetero-
zygous variants found in the context of 22q11.2 deletion
syndrome that were excluded from our phenotypic analysis.18
Patient 6 was included because his 370 kb deletion affected
only 3 OMIM genes other than SNAP29, for which no vari-
ants were detected; however, we cannot completely exclude
contribution of these genes to his neurologic phenotype.
In the 19 patients with homozygous or compound hetero-
zygous SNAP29 mutations reported earlier,1–9 no clear
genotype-phenotype correlation emerged (table 2). Com-
pared with previous reports, patients in this report had a
higher occurrence of seizures (3/6 vs 7/19) (p = 0.5741),
strabismus (4/6 vs 2/19) (p = 0.0060), early puberty in pu-
bescent patients (2/3 vs 1/2) (p = 0.7390), hypomyelination
(4/6 vs 3/16) (p = 0.0291), and constipation (3/6 vs 0/19) (p
= 0.0013) than previously reported (table 2). Although in-
creased reporting of findings such as constipation and strabis-
mus may be associated with changes in diagnosis since earlier
publications, other associations expand our understanding of
the disease phenotypes caused by SNAP29 variants.
These patients have widened the genotypic and phenotypic
spectrum of CEDNIK syndrome in several ways. First, 2 pa-
tients had early puberty, which was only reported in a single
previous case of CEDNIK syndrome.4 SNAP29 may play an
undiscovered role in sex hormone production because the
highest expression of SNAP29 is in the testes, and the ex-
pression in ovary is higher than all brain tissues analyzed.19
Given that many patients were prepubescent at time of pub-
lication, further investigation into the role of SNAP29 in en-
docrine regulation is required.
Second, we report a 19-year-old patient who may be the
longest-surviving individual diagnosed with CEDNIK syn-
drome. Patients 1 and 2 are respectively the oldest patient and
most neurologically functional patient described so far. We
hypothesize that these unique features are because of low-
level production of the c.2T>C; p.Met1? variant of SNAP29,
as transcripts with disrupted initiation codons can be trans-
lated using alternate start sites or alternate initiation codon
sequences.20 Evidence from one previously reported patient
showed mRNA from the c.2T>C allele was detectable in the
blood, but Western blotting of fibroblasts did not detect
SNAP29 protein expression.7 It is unknown whether low
levels of SNAP29 not detectable by Western blot could be
mitigating the phenotypes of patients 1 and 2.
Third, we present a novel nonsense mutation in the final exon,
c.622G>T (p.Glu208*), suggesting production of a truncated
protein. All previously reported frameshift and nonsense vari-
ants are predicted to cause loss of function through nonsense-
mediatedmRNAdecay (NMD). This truncated protein is likely
not functional, given the patient’s significant disease burden,
with corpus callosum and white matter loss, profound hypo-
tonia, blindness, deafness, and dysmorphic features. It is possible
that this variant has unique function, for example, interfering
with soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNAP)/SNAP receptor (SNARE) complex
formation because of interruption of the C-SNARE domain.
Fourth, brain imaging of these patients identified several ab-
normalities not previously associated with CEDNIK syn-
drome. Four of 6 patients had white matter changes
consistent with significantly decreased myelin content. Pa-
tient 1’s loss of myelin between age 14 months and 12 years of
age seems radiographically similar to Pelizaeus-Merzbacher
disease and could represent progressive hypomyelination.
Although the c.2T>C variant (carried by patients 1 and 2) was
described in a patient with hypomyelinating leukodystrophy
diagnosed with PMLD,7 the phenotype does not seem to be
exclusive to this variant because other patients (patients 4, 6,
Figure 4 Brain MRI of Patient 5 Shows Small Frontal Lobes,
Abnormal Sylvian Fissures, and T2 Hyperintensity
of the Globus Pallidus
Axial T1W and T2W images at (A) 4 days of life and (B) at 10 month old.
Structural findings include small frontal lobes and abnormal Sylvian fissures
(orange arrows). Myelination in the newborn period is normal above the
tentorium because only the posterior limb of the internal capsule should be
myelinated.22 (B) At 10 months, there is subtle hypomyelination in the oc-
cipital regions, but some normal myelin is seen in the genu of the corpus
callosum. There is high T2W signal in the globus pallidus bilaterally (cyan
arrow).
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Table 2 Clinical Phenotypes Associated With CEDNIK Syndrome
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0/4 Yes Yes Yes No No Yes 7/13
(54%)



























N/A No No Yes No No No 10/21
(48%)






N/A No No No Yes Yes No 3/14
(21%)






N/A Yes Yes Yes No Yes No 6/12
(50%)






N/A No No Yes Yes No Yes 9/21
(43%)
Dermatologic






0/4 Yesa Yes Yes Yes Yes Yes 20/25
(80%)






0/4 Yes Yes Yes No No Yes 17/25
(68%)
Continued
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and 2 previously described cases of CEDNIK syndrome4,5) had
imaging evidence consistent with hypomyelination/white
matter loss. Thus, there is growing evidence that hypomyeli-
nation may be a feature of CEDNIK syndrome, supported by
data showing high SNAP29 expression in myelinating glial
cells.21 Serial imaging in future patients could help determine
which SNAP29 variants are associated with this pattern of white
matter disease. In addition, abnormal craniocervical junction
(C1-C2) anatomy in our patients led to narrowing of the fo-
ramen magnum and kinking of the medulla. Although patients
with both SNAP29 and TUBA8 variants had loss of the pon-
tomedullary junction,8,9 our findings have not been previously
described in patients with CEDNIK syndrome and whether
they contribute to the disease phenotype is uncertain.
Finally, there are a growing number of patients in the literature
with SNAP29 pathogenic variants were not diagnosed with
CEDNIK syndrome because of the lack of ichthyosis or
keratoderma.7–9 In fact, keratoderma and ichthyosis were de-
scribed in only 80% and 68% of cases, respectively (table 2). One
such patient who was compound heterozygous for c.2T>C and
c.354dupG variants in SNAP29 was diagnosed with PMLD.7
Although previous homozygous cases of c.2T>C and c.354dupG
had skin findings typical of CEDNIK syndrome, this compound
heterozygous patient did not, suggesting reduced penetrance of
dermatologic disease with SNAP29 loss-of-function. This is
supported by Snap29-deficient mouse models, suggesting that
genetic or nongenetic modifiers affect skin findings.13 The lack of
dermatologic findings in these patients canmislead clinicians who
may fail to test for SNAP29 variants. Furthermore, only a few of
the recently reported patients had PMG or neuropathy typical of
CEDNIK syndrome, although neuropathy has not been sys-
tematically evaluated. We believe that the skin findings, cerebral
dysgenesis, and neuropathy that were initially thought to be
cardinal features of this condition are notmandatory to establish a
disease diagnosis.
Given incomplete penetrance for ichthyosis, keratoderma,
neuropathy, and cerebral dysgenesis phenotypes in patients
with SNAP29 pathogenic variants (table 2), we propose the
nomenclature SNAP29-related disorder instead of CEDNIK
syndrome for all patients with deleterious SNAP29 variants
regardless of their phenotypic features.
We report 6 new patients with predicted loss-of-function variants
in SNAP29. All patients exhibit DD, ichthyosis and/or palmo-
plantar keratoderma, and hypotonia. We highlight previously
under-recognized features such as supratentorial hypomyelina-
tion, seizures, and early puberty. We also find growing evidence
for reduced penetrance for the skin phenotype, cerebral dys-
genesis, and neuropathy. Significant phenotypic variability in
patients with SNAP29 variants suggests that CEDNIK syndrome
should be defined genetically rather than as a specific constel-
lation of neurologic, brain imaging, and skin findings.
Table 2 Clinical Phenotypes Associated With CEDNIK Syndrome (continued)




4 Pt 5 Pt 6 Total
Dysmorphic features






0/4 No No Yes Yes Yes Yesa 18/25
(72%)
Face shape Elongated (8)1,2, round (2)Pt1,Pt2, short forehead w/bitemporal narrowing (1)Pt5, brachycephaly/triangular (2)3, plagiocephaly (1)Pt3
Eyes Hypertelorism (10)1,5,Pt1,Pt2, deep-set (3)4,Pt1,Pt2, downslanting palpebral fissures (9)1,3, epicanthal folds (4)6,Pt3,Pt5,Pt6,
microphthalmia (1)Pt5
Ears Large ears (1)4, low-set ears (2)5,Pt5, small ears with folded helix (2)3
Nose Flat, broad root (11)1,3,5,Pt6, large/long (2)2,4, pointed tip (2)2, bulbous tip (1)Pt3, anteverted nares (1)Pt5, midface hypoplasia (1)6
Mouth Small chin (1)2, short philtrum (1)Pt5, retrognathia (1)6, micrognathia + high-arched palate (4)2,3,Pt5, bifid uvula (1)4
Ectodermal Sparse, brittle hair (2)2, thin hair at temples (1)Pt3, hirsuitism/low hairline (1)4, synophrys (3)4,5,Pt6, hypohidrosis (1)4, enamel
hypoplasia (1)5
Skeletal Talipes equinovarus (1)2, knee contractures (1)2, coxa valga (1)4, camptodactyly (2)3, radial deviation of wrists (2)3, clinodactyly (2)4,5
Other Small fontanelles (2)2, scarring alopecia(1)2, flat maxilla (1)3, colpocephaly (3)8, inverted nipples (1)2, single palmar crease (1)Pt3
Denominator can be different from 25 based on availability of data.
“N/A” – clinical phenotype not assessed. Otherwise data were explicitly stated or inferred negative if not mentioned. Respiratory infections include recurrent
viral illness and pneumonia. Early puberty was not assessed for girls <8 and boys <9 year old. Hypomyelination includes leukodystrophy, white matter T2
hyperintensity, andwhitematter loss. Spasticity includes hyperreflexivity, hypertonia, and hamstring or Achilles tendon tightness; patients without spasticity
were hyporeflexive or flaccid. Spasticity and scoliosis were not assessed for infants <1 year old.
Dysmorphic features listed with (No. of patients affected)reference.
a Mild or moderate phenotype.
b Intermittent exotropia.
c Uncertain.
d Deaths from pneumonia/respiratory infection.
e Collodion phenotype.
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